GLP-1 medications can feel like a Rorschach test online: one person calls Ozempic or Wegovy a miracle, another calls it miserable, and almost nobody explains what the “normal middle” looks like. We wanted to fix that with a practical walkthrough of what tends to happen after you start a GLP-1 receptor agonist, especially in those first weeks when you’re on a low dose and you’re wondering if anything is happening at all.
We talk through the early ramp-up, realistic weight loss expectations, and the biggest lived experience change we hear from patients: food noise getting quieter. We break down the difference between normal hunger cues and constant appetite chatter, why cravings often drop, and how that creates a real window of opportunity to build routines that used to be hard. We also get honest about common side effects like nausea, constipation, and feeling overly full, plus simple strategies that can make them more manageable and safer.
Then we zoom out to the long game: what it means to treat obesity as a chronic condition, why plateaus don’t automatically mean the medication “stopped working,” and how to define success beyond a single scale number using cardiometabolic health wins. After the clinical talk, we lighten things up with some banter about Ollie’s pet store obsession and the strange things strangers say on a walk.
If this helped you, subscribe, share it with a loved one, and leave a review so more people can find practical, judgment-free education on GLP-1s and healthy weight loss.
Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN
Artwork Rebrand and Avatars:
Vantage Design Works (Vanessa Jones)
Website: https://www.vantagedesignworks.com/
Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr
Original Artwork Concept: Olivia Pawlowski
